Unlocking Microbiome Science
As an early pioneer in microbiome science, OpenBiome laid the foundation for microbiome-based therapies by providing access to investigational fecal microbiota transplantation (FMT). We're now leveraging our experience and expertise to catalyze microbiome research worldwide.
How We Work
Catalyzing Research: Build and share the world's most globally representative microbiome library.
Advancing Therapies: Alleviate suffering around the world—starting with Clostridioides difficile and malnutrition.
Expanding Scientific Capacity: Support and train frontline researchers in low-or middle-income countries.
OpenBiome, through its flagship program the Global Microbiome Conservancy (GMbC), is providing scientists with tools and resources to make breakthrough discoveries.
Currently, microbiome research is limited by a biased and narrow view of the microbiome that focuses on U.S. and European populations.
The GMbC library—containing samples from more than 1,200 participants from over 30 underpresented communities—fills this critical gap by providing scientists with a radically expanded view of the microbiome and access to previously unavailable biodiversity
“Over the past decade, we’ve shown the transformative power of the microbiome through investigational FMT for patients with recurrent C. difficile. We’re excited to take the next step and use our expertise to catalyze microbiome research around the world.”
— Julie Barrett O’Brien, Chief Executive Officer at OpenBiome